A Tijuana, Mexico-based cancer treatment facility, Oasis of Hope has treated more than 100,000 patients from around the world. Directed by Dr. Francisco Contreras, Oasis of Hope provides state-of-the-art cancer treatments in combination with research-based cancer-fighting nutrient therapies.
Vitamin K3, also known as menadione, is administered to patients with cancer at Oasis of Hope who are receiving vitamin C infusions as a form of cancer therapy. Provided via an injection, vitamin K is given in advance of the infusions to help boost vitamin C’s effectiveness at increasing the level of hydrogen peroxide in cancer cells. Vitamin K facilitates the transfer of electrons to oxygen molecules from vitamin C and, as a result, promotes the production of cancer-killing hydrogen peroxide.
Animal and human studies have proven the efficacy of injectable vitamin K in enhancing vitamin C therapy in cancer patients, with much of this research conducted at the Catholic University of Louvain, Belgium. Research has demonstrated that the use of a combination of vitamin C and vitamin K for cancer treatment offers multiple advantages. For example, the treatment is well-tolerated and can be used in conjunction with chemotherapy drugs to enhance their ability to destroy cancer cells.
